Sex Differences in Minocycline-Induced Neuroprotection after Experimental Stroke
Open Access
- 4 February 2009
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 29 (4), 670-674
- https://doi.org/10.1038/jcbfm.2009.3
Abstract
Minocycline is neuroprotective in clinical and experimental stroke studies, due in part to its ability to inhibit poly (ADP-ribose) polymerase. Previous preclinical data have shown that interferenc...Keywords
This publication has 20 references indexed in Scilit:
- Sex Differences in Caspase Activation After StrokeStroke, 2009
- Pathways to ischemic neuronal cell death: are sex differences relevant?Journal of Translational Medicine, 2008
- The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signalsEuropean Journal of Neuroscience, 2004
- PARP‐1 gene disruption in mice preferentially protects males from perinatal brain injuryJournal of Neurochemistry, 2004
- Poly(ADP-ribose) Polymerase-1-mediated Cell Death in Astrocytes Requires NAD+ Depletion and Mitochondrial Permeability TransitionPublished by Elsevier BV ,2004
- Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents*Critical Care Medicine, 2002
- Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug DevelopmentStroke, 1999
- A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic windowProceedings of the National Academy of Sciences of the United States of America, 1999
- Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemiaNature Medicine, 1997
- Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New ZealandJournal of Neurosurgery, 1996